Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 1031

1.

Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).

Schmitz KJ, Lang H, Kaiser G, Wohlschlaeger J, Sotiropoulos GC, Baba HA, Jasani B, Schmid KW.

Hum Pathol. 2009 Dec;40(12):1706-14. doi: 10.1016/j.humpath.2009.01.026. Epub 2009 Aug 14.

PMID:
19683330
3.

Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.

Iguchi T, Aishima S, Taketomi A, Nishihara Y, Fujita N, Sanefuji K, Sugimachi K, Yamashita Y, Maehara Y, Tsuneyoshi M.

Hum Pathol. 2009 Feb;40(2):174-80. doi: 10.1016/j.humpath.2008.06.029. Epub 2008 Oct 5.

PMID:
18835624
4.

Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.

Xu Y, Zhu M, Zhang S, Liu H, Li T, Qin C.

Pathol Oncol Res. 2010 Jun;16(2):169-75. doi: 10.1007/s12253-009-9200-y. Epub 2009 Sep 9.

PMID:
19757198
5.

Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.

Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Iguchi T, Taketomi A, Maehara Y, Tsuneyoshi M.

Hum Pathol. 2007 Dec;38(12):1819-25. Epub 2007 Sep 14.

PMID:
17854859
6.

Expression of matrix metalloproteinase 2 and extracellular matrix metalloproteinase inducer are unfavorable postoperative prognostic factors in intrahepatic cholangiocarcinoma.

Zhang C, Tu Z, Du S, Wang Y, Wang Q.

Pathol Oncol Res. 2010 Mar;16(1):47-53. doi: 10.1007/s12253-009-9186-5. Epub 2009 Jul 25.

PMID:
19629755
7.

CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.

Su MC, Hsu C, Kao HL, Jeng YM.

Cancer Lett. 2006 Apr 8;235(1):34-9. Epub 2005 Aug 25.

PMID:
16125303
8.

Origin and pathological characteristics of Klatskin tumor: a case report and literature review.

Somer L, Andrejić B, Milošević P.

Pol J Pathol. 2012 Mar;63(1):65-70. Review.

PMID:
22535609
9.

[Classification and staging systems for hilar cholangio-carcinoma (Klatskin tumors): clinical application and practical relevance].

Gavrilovici V, Grecu F, Seripcariu V, Dragomir C.

Rev Med Chir Soc Med Nat Iasi. 2011 Apr-Jun;115(2):412-7. Romanian.

PMID:
21870733
10.

CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.

Nishihara Y, Aishima S, Hayashi A, Iguchi T, Fujita N, Taketomi A, Honda H, Tsuneyoshi M.

Histopathology. 2009 Oct;55(4):423-31. doi: 10.1111/j.1365-2559.2009.03398.x.

PMID:
19817893
11.

[Surgical therapy of hilar cholangiocarcinoma].

Lang H, Kaiser GM, Zöpf T, Sotiropoulos GC, Frilling A, Malagó M, Broelsch CE.

Chirurg. 2006 Apr;77(4):325-34. German.

PMID:
16568258
12.

The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma.

Romani AA, Crafa P, Desenzani S, Graiani G, Lagrasta C, Sianesi M, Soliani P, Borghetti AF.

BMC Cancer. 2007 Dec 21;7:232.

13.

[Gallbladder and bile duct carcinoma. Biology and pathology].

Tannapfel A, Wittekind C.

Internist (Berl). 2004 Jan;45(1):33-41. Review. German.

PMID:
14735242
14.

Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma.

Aishima S, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M.

Mod Pathol. 2008 Mar;21(3):256-64. doi: 10.1038/modpathol.3800985. Epub 2008 Jan 11.

15.

In-continuity hepatic resection for advanced hilar cholangiocarcinoma.

Zervos EE, Pearson H, Durkin AJ, Thometz D, Rosemurgy P, Kelley S, Rosemurgy AS.

Am J Surg. 2004 Nov;188(5):584-8.

PMID:
15546575
16.

Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma.

Zhou L, He XD, Cui QC, Zhou WX, Qu Q, Zhou RL, Rui JA, Yu JC.

Cancer Lett. 2008 Jun 18;264(2):209-17. doi: 10.1016/j.canlet.2008.01.025. Epub 2008 Mar 10.

PMID:
18334282
17.

Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.

Li Q, Wang JM, Liu C, Xiao BL, Lu JX, Zou SQ.

Hepatobiliary Pancreat Dis Int. 2008 Feb;7(1):70-5.

18.

Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, Cappellani A, Malfermoni G, Iacono C.

World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.

PMID:
19294467
19.

The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.

Aishima S, Asayama Y, Taguchi K, Sugimachi K, Shirabe K, Shimada M, Sugimachi K, Tsuneyoshi M.

Mod Pathol. 2002 Nov;15(11):1181-90.

20.

The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma.

Sugimachi K, Aishima S, Taguchi K, Tanaka S, Shimada M, Kajiyama K, Sugimachi K, Tsuneyoshi M.

J Hepatol. 2001 Jul;35(1):74-9.

PMID:
11495045
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk